Pharmacokinetic evaluation in dogs of theophylline in a novel zero-order release core-in-cup tablet

Biopharmaceutics and Drug Disposition

Volumn 19, Issue 8, 1998, Pages 517-522

  Danckwerts, Michael P ^a   Van der Watt, Jakkie G ^b   Moodley, Indres ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Core in cup tablet; Dog; Pharmacokinetics; Theophylline; Zero order release

Indexed keywords

THEOPHYLLINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG FORMULATION; DRUG RELEASE; FEMALE; NONHUMAN; ORAL DRUG ADMINISTRATION; TABLET; TABLET MANUFACTURE; THEOPHYLLINE BLOOD LEVEL;

ANIMALS; AREA UNDER CURVE; BRONCHODILATOR AGENTS; DELAYED-ACTION PREPARATIONS; DOGS; FEMALE; TABLETS; THEOPHYLLINE;

EID: 0031740401     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(1998110)19:8<517::AID-BDD132>3.0.CO;2-B     Document Type: Article

References (22)

1. W.D. Rhine, D.S.T. Hsieh and R. Langer, Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. J. Pharm. Sci., 69, 265-270 (1980).
2. J.L. Ford, M.H. Rubenstein, F. McCaul, J.E. Hogan and P.J. Edgar, Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Int. J. Pharm., 40, 223-234 (1987).
3. D.S.T. Hsieh, W.D. Rhine and R. Langer, Zero-order controlled release polymer matrices for micro-and macromolecules. J. Pharm. Sci., 72, 17-22 (1983).
4. M.A. Gonzalez and A.L. Golub, Theo-dur® and Theo-dur Sprinkle TM™ controlled-release delivery systems for theophylline. Drug Dev. Ind. Pharm., 9, 1379-1396 (1983).
5. M. Bialer, K. Salame and I. Raz, The effect of sustained-release on the pharmacokinetics of theophylline on healthy subjects. Int. J. Clin. Pharmacol. Ther. Toxicol., 23, 662-667 (1985).
6. K.P. Devi, K.V. Rango Rao, S.K. Baveja, M. Fathi and M. Roth, Zero-order release formulation of oxprenolol hydrochloride with swelling and erosion control. Pharm. Res., 6, 313-317 (1989).
7. Y. Seta, F. Higuchi, Y. Kawahara, K. Nishimura and R. Okada, Design and preparation of captopril sustained-release dosage forms and their biopharmaceutical properties. Int. J. Pharm., 41, 245-254 (1988).
8. M.P. Danckwerts, Development of a zero-order release oral compressed tablet with potential for commercial tabletting production. Int. J. Pharm., 112, 37-45 (1994).
9. M.P. Danckwerts and J.G. van der Watt, The effect of processing variables on the compression properties of controlled release core-in-cup compressed tablets from a new adjustable punch. Int. J. Pharm., 123, 85-94 (1995).
10. M.P. Danckwerts, J.G. van der Watt and I. Moodley, The effect of processing variables on the release of ibuprofen and caffeine from controlled release nonswellable core-in-cup compressed tablets. Drug Dev. Ind. Pharm., 22 (7), 681-687 (1996).
11. M. Bialer, S. Sussan, O. Abu Salach, H.D. Danenberg, J. Ben-David, Y. Gibor and A. Laor, Criteria to assess in vivo performance of sustained release products: Application to diltiazem sustained release formulations. J. Pharm. Sci., 84, 1160-1163 (1995).
12. J.D. Davis, L. Aarons and J.B. Houston, Simultaneous assay of fluoroquinolones and theophylline in plasma by high-performance liquid chromatography. J. Chromatogr., 621, 105-109 (1993).
13. J.G. Wagner and E. Nelson, Percent absorbed time plots derived from blood level and/or urinary excretion data. J. Pharm. Sci., 52, 610-611 (1963).
14. J.G. Wagner and E. Nelson, Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drug. J. Pharm. Sci., 53, 1392-1403 (1964).
15. K. Yamaoka, T. Nakagawa and T. Uno, Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm., 6, 165-175 (1978).
16. B.P. Imbimbo, P. Martinelli, M. Rocchetti, G. Ferrari, G. Bassotti and E. Imbimbo, Efficiency of different criteria for selecting pharmacokinetic multiexponential equations. Biopharm. Drug Dispos., 12, 139-147 (1991).
17. H. Boxenbaum, Pharmacokinetic determinants in the design and evaluation of sustained-release dosage forms. Pharm. Res., 2, 82-88 (1984).
18. M. Gibaldi and D. Perrier, Pharmacokinetics. In Drugs and the Pharmaceutical Sciences, J. Swarbrick (Ed.), Marcel Dekker, New York, 1982, pp. 409-424, 433-457.
19. G.D. Koritz, B.C. McKiernan, C.A. Neff-Davis and I.J. Munsiff, Bioavailability of four slow-release theophylline formulations in beagle dog. J. Vet. Pharmacol. Therap., 9, 293-302 (1986).
20. Z. Hussein, M. Bialer, M. Friedman and I. Raz, Pharmacokinetic analysis of sustained-release dosage forms of theophylline in humans; comparison of single and multiple dose studies. Biopharm. Drug Dispos., 8, 427-435 (1987).
21. M. Bialer, S.A. Kaplan and A. Yacobi, Animal models in the primary screening of controlled release formulations. In Oral Sustained Release Formulations: Design and Evaluation, A. Yacobi and E. Halperin-Walega (Eds), Pergamon Press, New York, 1988, pp. 183-193.
22. M.P. Danckwerts, Development of zero-order release tablets, Ph.D thesis, University of the Witwatersrand, South Africa, 86-9, 1996.